leisure time -WSS

leisure time

author：focus 2025-09-07 06:37:31 - browse：2759

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Christmas in the PICU brings some surprising joy

WSS

Drinking less cuts risk of oral cavity, esophageal cancer: Report

SEC charges former device maker CEO with $41 million fraud

Bring on the sabbaticals for nurses

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Editas, Vertex strike deal on CRISPR

Pregnancy ages women, but effects reverse after delivery

hotspot

leisure time

Wikipedia

Activists slam private health insurers over coverage restrictions

Biotech investment managers search for lucrative opportunities

Duchenne breakthrough therapy leaves behind pioneering families

Drinking less cuts risk of oral cavity, esophageal cancer: Report

In age of alternative facts, a scholarly course on calling out crap

Surgeons perform first xenotransplant using CRISPR'd pig kidney

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Pfizer, Moderna say biotech, pharma drug development is a sprint

Supreme Court strikes down use of affirmative action

Why health records don't always know when patients are dead

hotspot

Biotech investment managers search for lucrative opportunities

Violet CEO on training clinicians to promote more inclusive care

Christmas in the PICU brings some surprising joy

In Spain, a hospital brews its own CAR

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Can sheer will power keep patients alive in their dying hours?

focus

explore

hotspot

hotspot